Key Dates
- Board Meeting Date: Saturday, May 30, 2026
- Disclosure Date: May 25, 2026
- Financial Period: Quarter and financial year ended March 31, 2026
Agenda Items
The Board will consider and approve:
1. The Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026
2. The proposal for raising funds through issuance of equity shares and/or other eligible securities, including convertible warrants, on a preferential basis
Fundraising Details
- Potential Investors: Promoter(s), Promoter Group and/or Non-Promoter investors
- Approval Requirements: Subject to receipt of necessary regulatory, statutory, stock exchange and shareholders' approvals
- Legal Framework: As required under applicable laws and regulations
Financial Impact
Financial impact not quantified in the disclosure. The actual fundraising amount and terms will be determined subject to board approval and subsequent regulatory approvals.